BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22588556)

  • 1. Risk of liver cancer among US male veterans with cirrhosis, 1969-1996.
    Persson EC; Quraishi SM; Welzel TM; Carreon JD; Gridley G; Graubard BI; McGlynn KA
    Br J Cancer; 2012 Jun; 107(1):195-200. PubMed ID: 22588556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status.
    Torgersen J; Kallan MJ; Carbonari DM; Park LS; Mehta RL; D'Addeo K; Tate JP; Lim JK; Goetz MB; Rodriguez-Barradas MC; Gibert CL; Bräu N; Brown ST; Roy JA; Taddei TH; Justice AC; Lo Re V
    J Natl Cancer Inst; 2020 Jul; 112(7):747-755. PubMed ID: 31687755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
    Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
    J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
    Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
    Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
    Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for the rising rates of primary liver cancer in the United States.
    El-Serag HB; Mason AC
    Arch Intern Med; 2000 Nov; 160(21):3227-30. PubMed ID: 11088082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease.
    Yang JD; Ahmed F; Mara KC; Addissie BD; Allen AM; Gores GJ; Roberts LR
    Hepatology; 2020 Mar; 71(3):907-916. PubMed ID: 31309602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
    Ioannou GN; Green P; Kerr KF; Berry K
    J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection.
    Mittal S; Kramer JR; Omino R; Chayanupatkul M; Richardson PA; El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):252-259. PubMed ID: 28870660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis.
    McDonald SA; Pollock KG; Barclay ST; Goldberg DJ; Bathgate A; Bramley P; Dillon JF; Fraser A; Innes HA; Kennedy N; Morris J; Went A; Hayes PC; Hutchinson SJ
    J Viral Hepat; 2020 Mar; 27(3):270-280. PubMed ID: 31696575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection.
    Kramer JR; Kowalkowski MA; Duan Z; Chiao EY
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):456-62. PubMed ID: 25559606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies.
    Mair RD; Valenzuela A; Ha NB; Ayoub WS; Daugherty T; Lutchman GA; Garcia G; Ahmed A; Nguyen MH
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1412-7. PubMed ID: 22902757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
    Kramer JR; Giordano TP; Souchek J; Richardson P; Hwang LY; El-Serag HB
    Am J Gastroenterol; 2005 Jan; 100(1):56-63. PubMed ID: 15654781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
    Mohanty A; Tate JP; Garcia-Tsao G
    Gastroenterology; 2016 Feb; 150(2):430-40.e1. PubMed ID: 26484707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
    Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
    Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.
    Hung TH; Liang CM; Hsu CN; Tai WC; Tsai KL; Ku MK; Wang JW; Tseng KL; Yuan LT; Nguang SH; Yang SC; Wu CK; Hsu PI; Wu DC; Chuah SK
    PLoS One; 2017; 12(7):e0181858. PubMed ID: 28742130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.